Zacks Research Comments on Delek US’s Q2 Earnings (NYSE:DK)

Delek US Holdings, Inc. (NYSE:DK) – Zacks Research boosted their Q2 2027 earnings per share estimates for Delek US in a report released on Monday, July 13th. Zacks Research analyst Team now forecasts that the oil and gas company will post earnings per share of $0.61 for the quarter, up from their previous estimate of $0.56. Zacks Research has a “Strong-Buy” rating on the stock. The consensus estimate for Delek US’s current full-year earnings is $5.63 per share. Zacks Research also issued estimates for Delek US’s Q3 2027 earnings at $0.31 EPS and Q2 2028 earnings at $0.21 EPS.

Delek US (NYSE:DK) last released its quarterly earnings results on Wednesday, April 29th. The oil and gas company reported $0.08 earnings per share for the quarter, topping the consensus estimate of ($1.42) by $1.50. Delek US had a positive return on equity of 22.90% and a negative net margin of 0.48%.The company had revenue of $2.65 billion for the quarter, compared to analysts’ expectations of $2.33 billion. During the same period in the previous year, the business posted ($2.32) earnings per share. The business’s quarterly revenue was up .4% compared to the same quarter last year.

A number of other equities research analysts have also weighed in on DK. Wall Street Zen raised shares of Delek US from a “buy” rating to a “strong-buy” rating in a report on Monday, May 18th. Morgan Stanley raised their price target on shares of Delek US from $41.00 to $45.00 and gave the company an “equal weight” rating in a research note on Friday, June 12th. JPMorgan Chase & Co. lifted their price target on shares of Delek US from $57.00 to $62.00 and gave the stock a “neutral” rating in a report on Tuesday. UBS Group boosted their price objective on shares of Delek US from $42.00 to $48.00 and gave the stock a “neutral” rating in a research note on Friday, April 10th. Finally, Mizuho increased their price objective on Delek US from $54.00 to $60.00 and gave the company an “outperform” rating in a report on Wednesday, May 27th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, six have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $49.15.

Delek US Stock Up 5.0%

Shares of NYSE DK opened at $60.92 on Wednesday. The company has a 50 day simple moving average of $47.33 and a 200 day simple moving average of $40.54. The firm has a market cap of $3.73 billion, a PE ratio of -66.95, a price-to-earnings-growth ratio of 0.35 and a beta of 0.58. Delek US has a 1 year low of $19.81 and a 1 year high of $60.97. The company has a debt-to-equity ratio of 10.51, a current ratio of 0.76 and a quick ratio of 0.49.

Delek US Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, May 8th. Shareholders of record on Friday, May 1st were given a dividend of $0.255 per share. The ex-dividend date of this dividend was Friday, May 1st. This represents a $1.02 dividend on an annualized basis and a yield of 1.7%. Delek US’s dividend payout ratio is -112.09%.

Insider Activity

In other news, Director Vicky Sutil sold 1,871 shares of Delek US stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $48.00, for a total value of $89,808.00. Following the completion of the transaction, the director directly owned 29,368 shares of the company’s stock, valued at approximately $1,409,664. This trade represents a 5.99% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Laurie Z. Tolson sold 4,921 shares of the business’s stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $46.30, for a total value of $227,842.30. Following the completion of the transaction, the director directly owned 18,226 shares in the company, valued at $843,863.80. This represents a 21.26% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 39,270 shares of company stock worth $1,828,718. 3.56% of the stock is owned by insiders.

Institutional Investors Weigh In On Delek US

A number of hedge funds have recently added to or reduced their stakes in the business. Thoroughbred Financial Services LLC raised its holdings in shares of Delek US by 1.3% in the fourth quarter. Thoroughbred Financial Services LLC now owns 27,164 shares of the oil and gas company’s stock valued at $805,000 after purchasing an additional 348 shares during the last quarter. New York State Common Retirement Fund grew its holdings in shares of Delek US by 1.8% in the fourth quarter. New York State Common Retirement Fund now owns 22,048 shares of the oil and gas company’s stock valued at $654,000 after acquiring an additional 400 shares in the last quarter. Aster Capital Management DIFC Ltd increased its position in shares of Delek US by 23.2% during the fourth quarter. Aster Capital Management DIFC Ltd now owns 2,259 shares of the oil and gas company’s stock valued at $67,000 after acquiring an additional 425 shares during the last quarter. Caitong International Asset Management Co. Ltd boosted its position in Delek US by 95.6% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 884 shares of the oil and gas company’s stock worth $26,000 after purchasing an additional 432 shares during the last quarter. Finally, Orion Porfolio Solutions LLC increased its position in shares of Delek US by 2.2% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 23,244 shares of the oil and gas company’s stock valued at $492,000 after purchasing an additional 507 shares during the last quarter. 97.01% of the stock is currently owned by institutional investors.

Key Delek US News

Here are the key news stories impacting Delek US this week:

• Positive Sentiment: JPMorgan Chase & Co. raised its price target on Delek US from $57 to $62 and kept a neutral rating, signaling modest upside from current levels. Benzinga article on JPMorgan price target increase
• Positive Sentiment: Zacks Research increased its earnings estimates across several periods, including Q2 2026, Q3 2026, Q4 2026, FY2026, Q1 2027, Q4 2027, and FY2027, which suggests improving expectations for Delek US’s future earnings power.
• Positive Sentiment: Zacks Research reiterated a Strong-Buy rating on Delek US, reinforcing bullish sentiment around the company’s execution and outlook.
• Neutral Sentiment: MarketBeat/analyst coverage notes Delek US has hit a new 1-year high, but the article frames it as a valuation question rather than a new fundamental catalyst. Article on Delek US hitting a new 1-year high
• Neutral Sentiment: Comparative refining-stock coverage versus PBF Energy highlights Delek’s stronger recent execution, but does not point to a new company-specific event. Zacks comparison article

Delek US Company Profile

Delek US Holdings, Inc (NYSE: DK) is an independent downstream energy company engaged in the refining, logistics, and marketing of petroleum products. Headquartered in Brentwood, Tennessee, the company operates a network of inland refineries, storage terminals and pipelines, and convenience store locations. Delek US focuses on converting crude oil into a variety of finished products, including gasoline, diesel, jet fuel, asphalt and renewable fuels, serving wholesale and retail customers across the United States.

In its refining segment, Delek US owns and operates four inland refineries located in Texas and Arkansas.